- Home
- ACFN vs STRO Comparison
ACFN vs STRO Comparison
Compare ACFN & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- STRO
- Stock Information
- Founded
- ACFN 1986
- STRO 2003
- Country
- ACFN United States
- STRO United States
- Employees
- ACFN N/A
- STRO N/A
- Industry
- ACFN Military/Government/Technical
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACFN Consumer Discretionary
- STRO Health Care
- Exchange
- ACFN Nasdaq
- STRO Nasdaq
- Market Cap
- ACFN 76.5M
- STRO 69.1M
- IPO Year
- ACFN N/A
- STRO 2018
- Fundamental
- Price
- ACFN $29.77
- STRO $0.88
- Analyst Decision
- ACFN
- STRO Hold
- Analyst Count
- ACFN 0
- STRO 7
- Target Price
- ACFN N/A
- STRO $1.97
- AVG Volume (30 Days)
- ACFN 25.8K
- STRO 598.8K
- Earning Date
- ACFN 11-06-2025
- STRO 11-12-2025
- Dividend Yield
- ACFN N/A
- STRO N/A
- EPS Growth
- ACFN 1520.82
- STRO N/A
- EPS
- ACFN 2.84
- STRO N/A
- Revenue
- ACFN $13,202,000.00
- STRO $104,473,000.00
- Revenue This Year
- ACFN N/A
- STRO $65.42
- Revenue Next Year
- ACFN N/A
- STRO N/A
- P/E Ratio
- ACFN $10.50
- STRO N/A
- Revenue Growth
- ACFN 50.98
- STRO N/A
- 52 Week Low
- ACFN $17.22
- STRO $0.52
- 52 Week High
- ACFN $33.00
- STRO $4.80
- Technical
- Relative Strength Index (RSI)
- ACFN N/A
- STRO 47.46
- Support Level
- ACFN N/A
- STRO $0.90
- Resistance Level
- ACFN N/A
- STRO $1.01
- Average True Range (ATR)
- ACFN 0.00
- STRO 0.09
- MACD
- ACFN 0.00
- STRO -0.00
- Stochastic Oscillator
- ACFN 0.00
- STRO 13.40
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.